Skip to main content

Table 1 List of significantly different endpoints after Mann-Whitney statistical analysis of non- progression (No Progr) versus progression (Progr) subgroups, together with their relative p values (significant p < 0.05)

From: Renal cancer: new models and approach for personalizing therapy

SIGNIFICANT PROTEINS

Progr vs No Progr

p value

Vimentin

0.004

HIF-1α

0.005

4E-BP1 (T70)

0.006

Cyclin D1

0.006

4E-BP1 (S65)

0.009

4E-BP1 (T37/46)

0.009

EGFR (Y1148)

0.014

KRAS

0.018

PKCθ (T538)

0.023

IkBα (S32/36)

0.027

mTOR (S2448)

0.028

PLCγ1 (Y783)

0.028

PKCα (S657)

0.028

PKCζ/λ (T410/403)

0.028

SGK1 (S78)

0.028

Cox2

0.028

cKIT (Y703)

0.039